Amrutanjan Health Care Limited has informed the Exchange regarding Appointment of Mr. Ramaswami Krishnan as Non- Executive Independent Director of the company w.e.f. May 08, 2026.
AMRUTANJAN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Amrutanjan Health Care Limited's Board of Directors has approved two key appointments at its meeting on 8 May 2026. First, Mr. Ramaswami Krishnan (65), a qualified CA, CS, CWA with Ph.D and MBA degrees, has been appointed as Additional Director and designated as Non-Executive Independent Director for a 5-year term from 8 May 2026 to 7 May 2031, subject to shareholder approval. He previously served as Director Finance & Marketing and Company Secretary at Malladi Drugs and Pharmaceuticals Limited. Second, Mr. Muralidharan Swayambunathan, who has 37+ years of experience across industries including TVS Sundaram and international airports, has been re-appointed as Non-Executive Independent Director for a second 5-year term from 29 June 2026 to 28 June 2031, also subject to shareholder approval. Both appointments follow the recommendation of the Nomination and Remuneration Committee.
The appointment of an experienced finance professional like Mr. Krishnan and the re-appointment of Mr. Swayambunathan strengthen the board's independent oversight. Both appointments are positive for governance but are routine in nature and unlikely to have immediate impact on the stock price.